Sail Biomedicines

Sail Biomedicines is pioneering the development of programmable medicines. Their innovative platform combines two key technologies: Endless RNA™ (eRNA™) and programmable nanoparticles. eRNA is a proprietary circular RNA technology that enables the sustained delivery and expression of therapeutic molecules. Sail Biomedicine has developed a platform of natural nanoparticles that can be precisely engineered to deliver eRNA to target tissues. Sail Biomedicines' programmable nanoparticles can be designed to deliver eRNA to specific tissues and cell types allowing for precision targeting. Their eRNA technology allows for the long-term expression of therapeutic molecules. By leveraging these technologies, Sail Biomedicines aims to create a new generation of medicines with unprecedented performance and broad applicability. Their focus areas include oncology, metabolic disease, infectious diseases, rare diseases, and immunology.